Home › Research › Topics › roles
roles
8 studies tagged roles, dated 2003-04-01 to 2024-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease 2024-01-01
- Roles of TREM2 in the Pathological Mechanism and the Therapeutic Strategies of Alzheimer's Disease 2024-01-01
- Characteristics of plaque lipid-associated macrophages and their possible roles in the pathogenesis of atherosclerosis 2022-08-03
Studies
8 studies carry this tag.
Date range
2003 to 2024
Top journals
- Current opinion in lipidology 1
- Frontiers in cellular neuroscience 1
- International journal of geriatric psychiatry 1
- Neurochemical research 1
- Physiological reviews 1
8 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Alzheimer disease (AD) is associated with multiple etiologies and pathological mechanisms, among which oxidative stress (OS) appears as a major determinant.
-
45/100
Alzheimer's disease (AD) is an age-related degenerative disease, which is characteristic by the deposition of senile plaques (SP) outside the cells, the neurofibrillary tangles (NFTs) inside the neurons, and the loss of synapse and neurons.
-
Recent findings from single-cell transcriptomic studies prompted us to revisit the role of plaque foamy macrophages in the pathogenesis of atherosclerosis.
-
Sleep disturbances not only deteriorate Alzheimer's disease (AD) progress by affecting cognitive states but also accelerate the neuropathological changes of AD.
-
41/100
Recently, the critical roles played by genetic variants of TREM2 (Triggering Receptor Expressed on Myeloid cells 2) in Alzheimer's disease have been aggressively highlighted.
-
The profile of 10 FIBA-derived peptides combined with age would be a candidate biomarker for AD, which facilitates screening of the disease.
-
Humans have evolved much longer lifespans than the great apes, which rarely exceed 50 years.
-
The most important therapeutic effect of cholinesterase inhibitors (ChEI) on approximately 50% of Alzheimer's disease (AD) patients is to stabilize cognitive function at a steady level during a 1-year period of treatment as compared to placebo.